Notice of Meeting, 47793 [2020-17224]

Download as PDF 47793 Federal Register / Vol. 85, No. 152 / Thursday, August 6, 2020 / Notices Persons other than the registrants may sell, distribute, or use existing stocks of canceled products until supplies are exhausted, provided that such sale, distribution, or use is consistent with the terms of the previously approved labeling on, or that accompanied, the canceled products. Dated: July 28, 2020. Mary Reaves, Acting Director, Pesticide Re-Evaluation Division, Office of Pesticide Programs. [FR Doc. 2020–17114 Filed 8–5–20; 8:45 am] BILLING CODE 6560–50–P Receiver for each of the following insured depository institutions, was charged with the duty of winding up the affairs of the former institutions and liquidating all related assets. The Receiver has fulfilled its obligations and made all dividend distributions required by law. FEDERAL DEPOSIT INSURANCE CORPORATION Authority: 7 U.S.C. 136 et seq. Notice of Termination of Receiverships The Federal Deposit Insurance Corporation (FDIC or Receiver), as NOTICE OF TERMINATION OF RECEIVERSHIPS Fund Receivership name City 10145 ................. 10170 ................. United Security Bank ........................................................... Town Community Bank & Trust .......................................... Sparta ................................................... Antioch ................................................. The Receiver has further irrevocably authorized and appointed FDICCorporate as its attorney-in-fact to execute and file any and all documents that may be required to be executed by the Receiver which FDIC-Corporate, in its sole discretion, deems necessary, including but not limited to releases, discharges, satisfactions, endorsements, assignments, and deeds. Effective on the termination dates listed above, the Receiverships have been terminated, the Receiver has been discharged, and the Receiverships have ceased to exist as legal entities. (Authority: 12 U.S.C. 1819) Federal Deposit Insurance Corporation. Dated at Washington, DC, on August 3, 2020. James P. Sheesley, Acting Assistant Executive Secretary. [FR Doc. 2020–17208 Filed 8–5–20; 8:45 am] BILLING CODE 6714–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting Agency for Healthcare Research and Quality, HHS. AGENCY: jbell on DSKJLSW7X2PROD with NOTICES ACTION: Notice. The Agency for Healthcare Research and Quality (AHRQ) announces a Special Emphasis Panel (SEP) meeting on ‘‘HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10–ZHS1 SUMMARY: VerDate Sep<11>2014 17:13 Aug 05, 2020 Jkt 250001 HSR–F (01).’’ This SEP meeting will be closed to the public. DATES: August 26, 2020. ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20850. FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20850, Telephone: (301)427–1557. SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly-scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10–ZHS1 HSR–F (01)’’ is to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 State Termination date GA IL 8/1/2020 8/1/2020 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for this meeting are subject to change as priorities dictate. Dated: August 3, 2020. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2020–17224 Filed 8–5–20; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0424] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Temporary Marketing Permit Applications Food and Drug Administration, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Submit written comments (including recommendations) on the collection of information by September 8, 2020. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be submitted to https:// SUMMARY: E:\FR\FM\06AUN1.SGM 06AUN1

Agencies

[Federal Register Volume 85, Number 152 (Thursday, August 6, 2020)]
[Notices]
[Page 47793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17224]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel (SEP) meeting on ``HEALTHCARE 
INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-ZHS1 HSR-F (01).'' This 
SEP meeting will be closed to the public.

DATES: August 26, 2020.

ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20850.

FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20850, Telephone: (301)427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly-scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in particular review meetings which require their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. App. 2, section 
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications 
for the ``HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-
ZHS1 HSR-F (01)'' is to be reviewed and discussed at this meeting. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: August 3, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-17224 Filed 8-5-20; 8:45 am]
BILLING CODE 4160-90-P